[
  {
    "ts": "2025-12-01T13:18:00+00:00",
    "headline": "Johnson & Johnson receives European Commission approval of IMAAVY® (nipocalimab), a new FcRn blocker offering sustained disease control in a broad population of people living with generalised myasthenia gravis (gMG)",
    "summary": "Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive In the pivotal Phase 3 Vivacity-MG3 and Phase 2/3 Vibrance-MG studies over 24 weeks, nipocalimab demonstrated rapid and substantial reduction in immunoglobulin G levels, one of the root causes of gMG gMG patients taking nipocalimab demonstrated up to 20 months of sustained disease control and symptom relief in the Vivacity-MG3 study and ongoi",
    "url": "https://finance.yahoo.com/news/johnson-johnson-receives-european-commission-131800372.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "9b1cc7ab-1d04-391a-bf52-c2ec9ae3d594",
      "content": {
        "id": "9b1cc7ab-1d04-391a-bf52-c2ec9ae3d594",
        "contentType": "STORY",
        "title": "Johnson & Johnson receives European Commission approval of IMAAVY® (nipocalimab), a new FcRn blocker offering sustained disease control in a broad population of people living with generalised myasthenia gravis (gMG)",
        "description": "",
        "summary": "Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive In the pivotal Phase 3 Vivacity-MG3 and Phase 2/3 Vibrance-MG studies over 24 weeks, nipocalimab demonstrated rapid and substantial reduction in immunoglobulin G levels, one of the root causes of gMG gMG patients taking nipocalimab demonstrated up to 20 months of sustained disease control and symptom relief in the Vivacity-MG3 study and ongoi",
        "pubDate": "2025-12-01T13:18:00Z",
        "displayTime": "2025-12-01T13:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/e0d8c22e436cbd568cb1316cb5beb4b3",
          "originalWidth": 2690,
          "originalHeight": 510,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jFgHjEGtPkqKstjJ7xH84w--~B/aD01MTA7dz0yNjkwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/e0d8c22e436cbd568cb1316cb5beb4b3.cf.webp",
              "width": 2690,
              "height": 510,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/m.9C60wTcxkvOQOLX1h8uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/e0d8c22e436cbd568cb1316cb5beb4b3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-receives-european-commission-131800372.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-receives-european-commission-131800372.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-01T14:00:00+00:00",
    "headline": "National Veterinary Associates Appoints Leslie Storms as President, Ethos Veterinary Health",
    "summary": "National Veterinary Associates (NVA) today announced that Leslie Storms has been appointed President, Ethos Veterinary Health, effective immediately. She will also become an investor in the company. Ethos Veterinary Health is NVA's premier network of specialty and emergency care, comprised of over 140 hospitals and 1,500 team members across North America.",
    "url": "https://finance.yahoo.com/news/national-veterinary-associates-appoints-leslie-140000646.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "01d9e346-173e-3b83-8e65-50b6081382b8",
      "content": {
        "id": "01d9e346-173e-3b83-8e65-50b6081382b8",
        "contentType": "STORY",
        "title": "National Veterinary Associates Appoints Leslie Storms as President, Ethos Veterinary Health",
        "description": "",
        "summary": "National Veterinary Associates (NVA) today announced that Leslie Storms has been appointed President, Ethos Veterinary Health, effective immediately. She will also become an investor in the company. Ethos Veterinary Health is NVA's premier network of specialty and emergency care, comprised of over 140 hospitals and 1,500 team members across North America.",
        "pubDate": "2025-12-01T14:00:00Z",
        "displayTime": "2025-12-01T14:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b0003d609da2d60f7ddc113cd6953c0b",
          "originalWidth": 400,
          "originalHeight": 198,
          "caption": "National Veterinary Associates logo (PRNewsfoto/National Veterinary Associates)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/iuSFSEgODah8WkKX4up1Jg--~B/aD0xOTg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b0003d609da2d60f7ddc113cd6953c0b.cf.webp",
              "width": 400,
              "height": 198,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RUecmnBAEuZG4G_qiPsC_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b0003d609da2d60f7ddc113cd6953c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/national-veterinary-associates-appoints-leslie-140000646.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/national-veterinary-associates-appoints-leslie-140000646.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-01T14:20:00+00:00",
    "headline": "Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus",
    "summary": "MBX Biosciences' sharp rally highlights how Zacks' stock recommendations outpaced broader market gains across multiple portfolios.",
    "url": "https://finance.yahoo.com/news/zacks-approach-beat-markets-mbx-142000606.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5336f824-9fde-3627-bed7-8d788be7e0d0",
      "content": {
        "id": "5336f824-9fde-3627-bed7-8d788be7e0d0",
        "contentType": "STORY",
        "title": "Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus",
        "description": "",
        "summary": "MBX Biosciences' sharp rally highlights how Zacks' stock recommendations outpaced broader market gains across multiple portfolios.",
        "pubDate": "2025-12-01T14:20:00Z",
        "displayTime": "2025-12-01T14:20:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/44173c3d54a89d8e766f86abbc0f7e12",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4J2QQ1tRpFzUNI.lcJpvjA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/44173c3d54a89d8e766f86abbc0f7e12.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Dzmd_X96UZRczA.zRJCZFw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/44173c3d54a89d8e766f86abbc0f7e12.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-approach-beat-markets-mbx-142000606.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-approach-beat-markets-mbx-142000606.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MBX"
            },
            {
              "symbol": "CACI"
            },
            {
              "symbol": "PWR"
            },
            {
              "symbol": "COHR"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "AXS"
            },
            {
              "symbol": "AXS-PE"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "UNH"
            },
            {
              "symbol": "GTX"
            },
            {
              "symbol": "MNST"
            },
            {
              "symbol": "^IXIC"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "^DJI"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-01T10:00:00+00:00",
    "headline": "J&J’s US orthopedic leader leaves amid DePuy spinout process",
    "summary": "Leslie Storms started a new role on Monday as president of Ethos Veterinary Health.",
    "url": "https://www.medtechdive.com/news/jnj-orthopedic-leader-leaves/806621/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "99f7cfdc-267d-31e7-9951-659127bf8694",
      "content": {
        "id": "99f7cfdc-267d-31e7-9951-659127bf8694",
        "contentType": "STORY",
        "title": "J&J’s US orthopedic leader leaves amid DePuy spinout process",
        "description": "",
        "summary": "Leslie Storms started a new role on Monday as president of Ethos Veterinary Health.",
        "pubDate": "2025-12-01T10:00:00Z",
        "displayTime": "2025-12-01T10:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/d82f90884be50ed1c19fc4a02e49566f",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "The Johnson & Johnson logo is displayed at company offices on October 17, 2023, in Irvine, California.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YPXJZqxF7BJmReHw5lyn7Q--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/d82f90884be50ed1c19fc4a02e49566f.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/onWnbo4hCKT.I5.zbZgcDQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/d82f90884be50ed1c19fc4a02e49566f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/jnj-orthopedic-leader-leaves/806621/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-us-orthopedic-leader-100000816.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "SNN"
            },
            {
              "symbol": "SYK"
            },
            {
              "symbol": "ZBH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]